MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 10.11.2025
Land |
 Vereinigte Staaten |
IPO-Jahr |
- |
Branche |
Arzneimittelhersteller |
Börse |
NASDAQ CAPITAL |
Anteile |
71 M |
Marktkapitalisierung |
$ 653 M |
EBITDA (LTM) |
$ -3.27 M |
P/E (LTM) |
-41.45 |
P/S (LTM) |
4.82 |
EPS (LTM) |
-0.22 |
Andere Aktien der Branche "Arzneimittelhersteller"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Adamis Pharmaceuticals Corporation
ADMP
|
- | 0.86 % | $ 117 M | Nasdaq Capital Market | USA |
 |
Aerie Pharmaceuticals
AERI
|
- | - | $ 754 M | Nasdaq Global Market,SPB | USA |
 |
Agile Therapeutics
AGRX
|
- | 10.11 % | $ 58.2 M | Nasdaq Capital Market | USA |
 |
Alimera Sciences
ALIM
|
- | - | $ 142 M | Nasdaq Global Market | USA |
 |
Canopy Growth Corporation
CGC
|
$ 1.23 | - | $ 132 M | Nasdaq Global Select Market |  Canada |
 |
AcelRx Pharmaceuticals
ACRX
|
- | 7.5 % | $ 6.35 M | Nasdaq Global Market | USA |
 |
Cronos Group
CRON
|
$ 2.68 | - | $ 1.43 B | Nasdaq Global Market | Canada |
 |
DURECT Corporation
DRRX
|
- | - | $ 50.1 M | Nasdaq Capital Market | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
- | -0.1 % | $ 2.03 B | Nasdaq Global Select Market |  Schweden |
 |
HEXO Corp.
HEXO
|
- | 2.45 % | $ 38.1 M | NYSE | Canada |
 |
Catalent
CTLT
|
- | - | $ 11.5 B | NYSE,SPB | USA |
 |
Emergent BioSolutions
EBS
|
$ 12.96 | -0.08 % | $ 664 M | NYSE,SPB | USA |
 |
Eagle Pharmaceuticals
EGRX
|
- | -39.89 % | $ 27.7 M | Nasdaq Global Market,SPB | USA |
 |
Endo International plc
ENDP
|
- | - | $ 28.9 M | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Evoke Pharma
EVOK
|
- | - | $ 36.6 M | Nasdaq Capital Market | USA |
 |
Athenex
ATNX
|
- | -23.39 % | $ 1.76 M | Nasdaq Global Select Market | USA |
 |
Zomedica Corp.
ZOM
|
- | -0.21 % | $ 98 M | NYSE American | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
$ 21.5 | - | $ 2.05 B | Nasdaq Global Select Market |  France |
 |
Rockwell Medical
RMTI
|
$ 0.94 | - | $ 21.9 M | Nasdaq Global Market | USA |
 |
Evolus
EOLS
|
$ 5.65 | - | $ 350 M | Nasdaq Global Market | USA |
 |
Harrow Health
HROW
|
$ 46.78 | - | $ 1.53 B | Nasdaq Global Market | USA |
 |
China Pharma Holdings
CPHI
|
$ 1.31 | -3.32 % | $ 22.9 M | NYSE American |  China |
 |
Zynerba Pharmaceuticals
ZYNE
|
- | - | $ 55.5 M | Nasdaq Global Market,SPB | USA |
 |
Jupiter Wellness
JUPW
|
- | - | $ 33.6 M | Nasdaq Global Select Market | USA |
 |
OrganiGram Holdings
OGI
|
$ 1.72 | - | $ 402 M | Nasdaq Global Select Market | Canada |
 |
Organogenesis Holdings
ORGO
|
$ 4.21 | - | $ 554 M | Nasdaq Capital Market | USA |
 |
Bausch Health Companies
BHC
|
$ 7.41 | -4.63 % | $ 2.7 B | NYSE | Canada |
 |
Lannett Company
LCI
|
- | 1.15 % | $ 7.11 M | NYSE | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
$ 4.95 | 2.48 % | $ 69.6 M | Nasdaq Global Select Market | USA |
 |
Neoleukin Therapeutics
NLTX
|
- | - | $ 193 M | Nasdaq Global Select Market | Canada |
 |
Sundial Growers
SNDL
|
$ 1.66 | - | $ 3.37 M | Nasdaq Global Select Market | Canada |
 |
Sonoma Pharmaceuticals
SNOA
|
$ 3.65 | - | $ 4.53 M | Nasdaq Capital Market | USA |
 |
Tilray
TLRY
|
$ 9.18 | - | $ 5.67 B | Nasdaq Global Select Market | Canada |
 |
Aurora Cannabis
ACB
|
$ 4.23 | - | $ 86.3 M | NYSE | Canada |
 |
Pacira BioSciences
PCRX
|
$ 23.53 | - | $ 1.09 B | Nasdaq Global Select Market,SPB | USA |
 |
PetIQ
PETQ
|
- | 1.64 % | $ 400 M | Nasdaq Global Select Market,SPB | USA |
 |
ProPhase Labs
PRPH
|
- | - | $ 5.07 M | Nasdaq Capital Market | USA |
 |
Veru
VERU
|
$ 2.39 | 3.46 % | $ 322 M | Nasdaq Capital Market | USA |
 |
Perrigo Company plc
PRGO
|
$ 15.08 | 2.59 % | $ 2.07 B | NYSE | USA |
 |
Radius Health
RDUS
|
- | - | $ 1.42 B | Nasdaq Global Market | USA |
 |
Recro Pharma
REPH
|
- | -4.76 % | $ 65.3 M | Nasdaq Global Select Market | USA |
 |
Relmada Therapeutics
RLMD
|
$ 4.31 | - | $ 130 M | Nasdaq Global Select Market,SPB | USA |
 |
OptiNose
OPTN
|
- | - | $ 1.08 B | Nasdaq Global Select Market | USA |
 |
PLx Pharma
PLXP
|
- | -27.8 % | $ 2.56 M | Nasdaq Capital Market | USA |
 |
Solid Biosciences
SLDB
|
$ 5.29 | -0.38 % | $ 216 M | Nasdaq Global Select Market,SPB | USA |
 |
SCYNEXIS
SCYX
|
$ 0.67 | - | $ 32.1 M | Nasdaq Global Select Market | USA |
 |
Tricida
TCDA
|
- | - | $ 3.25 M | Nasdaq Global Select Market,SPB | USA |
 |
TherapeuticsMD
TXMD
|
$ 2.16 | - | $ 22.6 M | Nasdaq Global Select Market | USA |
 |
Viatris
VTRS
|
$ 12.76 | - | $ 15.5 B | Nasdaq Global Select Market,SPB | USA |